🇺🇸 FDA
Pipeline program

A clinical study is aimed at comparing the effectiveness of two types of cell therapy in treating anal fistulas associated with Crohn's disease.

PB_A&A-ASC-FISTULA_1

Phase 3 other active

Quick answer

A clinical study is aimed at comparing the effectiveness of two types of cell therapy in treating anal fistulas associated with Crohn's disease. for Anal or recto-cutaneous or recto-vaginal Crohn-related fistula is a Phase 3 program (other) at COLLEGIUM PHARMACEUTICAL, INC with 1 ClinicalTrials.gov record(s).

Program details

Company
COLLEGIUM PHARMACEUTICAL, INC
Indication
Anal or recto-cutaneous or recto-vaginal Crohn-related fistula
Phase
Phase 3
Modality
other
Status
active

Clinical trials